AlphAIAlphAI — Financial news for AI agents
finance.yahoo.com$AGL

Agilon: Q3 Earnings Snapshot

Agilon Health Inc. (AGL) reported Q3 net income of $34.9M, or $1.97 per share, beating analyst expectations of a loss. Revenue was $1.52B, also exceeding forecasts. The company expects full-year revenue between $5.87B and $5.89B. Shares have increased fivefold in the past year, closing at $95.76 on Wednesday.

Original reporting
finance.yahoo.com
Published Nov 4, 2026, 11:03 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 4, 2026, 11:10 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Agilon: Q3 Earnings Snapshot — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$AGLBullishHigh
01

Why it matters

The earnings surprise and strong revenue beat provide a fresh catalyst for traders.

02

Market read

Earnings beat likely supports a short‑term rally in AGL and may influence peer stocks.

03

What to watch

Future revenue guidance of $5.87‑$5.89B may be scrutinized for feasibility.

Relevance 8/10Novelty 8/10Timing: after-hours Wednesday

Background

Agilon Health is a senior‑focused health‑care provider listed on the NYSE.

Company-level read

Ticker impact

$AGLBullishHigh confidence
Context

Agilon Health reported Q3 net income of $34.9M and EPS of $1.97, beating Zacks' expected loss of $2.01 per share.

Expected impact

upward pressure as market prices in the earnings beat

Evidence & confidence

The surprise profit and revenue beat are fresh, material information that can move the stock immediately.

Market effects

Sector

Positive earnings may lift the senior‑focused health‑care services sector.

Regional

U.S. healthcare stocks could see modest gains.

Global

Limited to U.S. markets; no broader global effect.

Counterpoint

What could challenge this read

If the beat is already priced in, the stock could face short‑term profit‑taking.

Key entities

  • company
    Agilon Health Inc.

    Senior‑focused health‑care services provider.

Read at source← All news

StoryAgilon Health reports Q3 2026 beat and raises full‑year revenue and EBITDA guidance

Also covered by

2 outlets

Related articles

$AGLMed

Agilon Health Inc (AGL) (Q3 2026) Earnings Call Highlights: Guidance Raised as Adjusted

Agilon Health Inc (AGL) reported Q3 2026 earnings, beating guidance with adjusted EBITDA of $64M, up from -$91M in Q3 2025. The company raised full-year 2026 guidance and expects 40-50% ACO membership growth in 2027. However, Medicare Advantage membership declined 10% YoY, and medical costs remain high. The company plans to expand into new markets starting in 2028. AGL ended Q3 with $312M in cash and raised its year-end cash outlook to at least $175M.

finance.yahoo.com
$AGLMed

Agilon Health Q3 Earnings Call Highlights

Agilon Health (NYSE: AGL) reported a medical services expense ratio of 88.5% in Q3, down from 104% a year earlier. The company exceeded adjusted EBITDA guidance by $64M, citing favorable risk adjustments and cost trends. Agilon raised its full-year cash outlook to at least $175M and expects 40-50% ACO membership growth in 2027. CEO Tim O'Rourke highlighted clinical program expansions and plans for new market partnerships.

finance.yahoo.com
$AGLMed

agilon health, inc. (AGL): Revenue increased 6% to $1.52 billion Compared to the Same Period in the Prior Year Increases Full Year 2026 Guidance to Reflect Positive Third Quarter Results

agilon health, inc. (AGL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 agilon health Reports Third Quarter 2026 Results Revenue increased 6% to $1.52 billion Compared to the Same Period in the Prior Year Increases Full Year 2026 Guidance to Reflect Positive Third Quarter Results Westerville, O.H., November 4, 2026 – agilon health, inc.

SEC EDGAR 8-K